Global Impact, on behalf of the Advancing Health Online Initiative (AHO) and Gavi, The Vaccine Alliance, invests $12 million through the VaxSocial Initiative to implement innovative social media interventions to build vaccine confidence
May 01, 2024 10:34 ET
|
Global Impact
Geneva, Switzerland, May 01, 2024 (GLOBE NEWSWIRE) -- Global Impact, as fiscal sponsor for the VaxSocial Initiative, is pleased to announce the selection of seven organizations that will receive...
Giants of Cancer Care® Announces the 12th Annual Class of Inductees
May 01, 2024 09:00 ET
|
OncLive®
CRANBURY, N.J., May 01, 2024 (GLOBE NEWSWIRE) -- OncLive®, the nation’s leading multimedia resource for oncology professionals and Pfizer (platinum supporter), Exelixis (gold supporter) and...
Tevogen Bio Announces Full Year 2023 Financial Results and Upcoming Operational Objectives
May 01, 2024 08:05 ET
|
Tevogen Bio Inc
For full year 2023, the operating expenses for Tevogen Bio Inc were $8.8 million.
ImmuneSensor Therapeutics Appoints Veteran Biopharma Executive, Thomas W. Dubensky, Jr., Ph.D., as Chief Executive Officer
May 01, 2024 08:00 ET
|
ImmuneSensor Therapeutics
DALLAS, May 01, 2024 (GLOBE NEWSWIRE) -- ImmuneSensor Therapeutics, a clinical-stage biotherapeutics company focused on the development of best-in-class small molecule inhibitors and agonists of the...
PharmaTher’s Sairiyo Therapeutics Completes Clinical and Regulatory Package for Phase 1 Study of Patented Reformulated Cepharanthine
May 01, 2024 08:00 ET
|
PharmaTher Holdings Ltd.
TORONTO, May 01, 2024 (GLOBE NEWSWIRE) -- PharmaTher Holdings Ltd. (the “Company” or “PharmaTher”) (OTCQB: PHRRF) (CSE: PHRM), a specialty pharmaceutical company, announced today Sairiyo...
New YPrime Report Highlights eCOA's Impact on CNS Trials
May 01, 2024 08:00 ET
|
Y-Prime, LLC
YPrime has released a new report, Insights into CNS Clinical Trials, which demonstrates to sponsors how eCOA can help streamline CNS research.
Tessellate BIO Announces Appointment of Professor Sandra Strauss to Scientific Advisory Board
May 01, 2024 04:00 ET
|
Tessellate Bio
AMSTERDAM and LONDON, May 01, 2024 (GLOBE NEWSWIRE) -- Tessellate BIO, a preclinical stage biotechnology company with a focus on novel Synthetic Lethality approaches, today announces the appointment...
Pixalate’s Q1 2024 Delisted Connected TV (CTV) Apps Report: Over 17,000 CTV Apps Delisted Across Roku, Amazon Fire TV, Apple TV and Samsung Smart TV Apps in the Last 2 Years
April 30, 2024 14:13 ET
|
Pixalate Inc.
LONDON, April 30, 2024 (GLOBE NEWSWIRE) -- Pixalate, the market-leading fraud protection, privacy, and compliance analytics platform for Connected TV (CTV) and Mobile Advertising, today released the...
Pixalate’s March 2024 Global Top Grossing Mobile Apps Based on Open Programmatic Ad Revenue in the Apple App Store: ‘Happy Color® Art Coloring Book’ Leads in North America and EMEA
April 30, 2024 09:58 ET
|
Pixalate Inc.
LONDON, April 30, 2024 (GLOBE NEWSWIRE) -- Pixalate, the global market-leading ad fraud protection, privacy, and compliance analytics platform, today released March 2024 Global Top Grossing Mobile...
Pixalate’s March 2024 Global Top Grossing Mobile Apps Based on Open Programmatic Ad Revenue in the Google Play Store: ‘Kik - Messaging & Chat App’ Leads in North America
April 30, 2024 09:28 ET
|
Pixalate Inc.
LONDON, April 30, 2024 (GLOBE NEWSWIRE) -- Pixalate, the global market-leading ad fraud protection, privacy, and compliance analytics platform, today released March 2024 Global Top Grossing Mobile...